FindTrial
Sign In

Early exposure to sevoflurane on neurocognition for retinopathy of prematurity infants

Early exposure to sevoflurane on neurocognition for retinopathy of prematurity infants

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015665
Enrollment
Unknown
Registered
2018-04-13
Start date
2018-04-16
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognition

Interventions

Case series:Early exposure to sevoflurane

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 8 Years

Inclusion criteria

Inclusion criteria: Early exposure to sevoflurane for ROP

Exclusion criteria

Exclusion criteria: Other surgeries besides ROP

Design outcomes

Primary

MeasureTime frame
IQ;—

Countries

China

Contacts

Public ContactHong Zhao

Peking University People's Hospital

rayezhao@gmail.com8610 88325581

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026